Status:
ACTIVE_NOT_RECRUITING
Rostock International Parkinson's Disease Study (ROPAD)
Lead Sponsor:
CENTOGENE GmbH Rostock
Conditions:
Parkinson´s Disease
Eligibility:
All Genders
30-80 years
Brief Summary
Rostock International Parkinson's Disease Study - An International, multicenter, epidemiological observational study aiming at identification of LRRK2-positive patients, the recruitment of 25,000 PD p...
Detailed Description
Parkinson's disease (PD) is one of the most common neurodegenerative disorders worldwide, affecting approximately 1% of individuals older than 60 years and causes progressive disability. Clinical sig...
Eligibility Criteria
Inclusion
- Informed consent is obtained from the participant
- The participant has been clinically diagnosed with Parkinson's disease within the last 5 years (≤ 5 years)
- The participant is between 30 and 80 years old
Exclusion
Key Trial Info
Start Date :
May 30 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
25000 Patients enrolled
Trial Details
Trial ID
NCT03866603
Start Date
May 30 2019
End Date
December 31 2025
Last Update
September 20 2024
Active Locations (110)
Enter a location and click search to find clinical trials sorted by distance.
1
Tucson Neuroscience Research
Tucson, Arizona, United States, 85710
2
Pharmacology Research Institute
Encino, California, United States, 91316
3
Neuro-Pain Medical Center
Fresno, California, United States, 93710
4
University of California (UC) San Diego
La Jolla, California, United States, 92093